Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

about

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

Item

http://www.wikidata.org/entity/Q54942463

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@en

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@nl

type

Item

label

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@en

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@nl

prefLabel

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@en

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@nl

P1476

Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.

@en

P2093

Kiyoshi Migita

http://www.w3.org/2001/XMLSchema#string

Satoru Motokawa

http://www.w3.org/2001/XMLSchema#string

Shuzo Sato

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Asano

http://www.w3.org/2001/XMLSchema#string

P2860

The platelet serotonin-release assay.

A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics.

Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.

Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.

Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5387/FMS.2018-06

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29628468

http://www.w3.org/2001/XMLSchema#string

P932

5956084

http://www.w3.org/2001/XMLSchema#string